中国结直肠癌肝转移诊断和综合治疗指南(V2020)

2021-03-06 中华胃肠外科杂志

2020版《指南》包括结直肠癌肝转移的诊断和随访、预防、MDT 作用、手术治疗和局部毁损治疗、可达到“无疾病证据”状态结直肠癌肝转移的新辅助和辅助治疗、无法达到“无疾病证据”状态结直肠癌肝转移的综合治

中文标题:

中国结直肠癌肝转移诊断和综合治疗指南(V2020)

发布机构:

发布日期:

2021-03-06

简要介绍:

肝脏是结直肠癌血行转移最主要的靶器官,结直肠癌肝转移是结直肠癌治疗的重点和难点之一。为了提高我国结直肠癌肝转移的诊断和综合治疗水平,自2008开始编写《中国结直肠癌肝转移诊断和综合治疗指南》并后续进行了多次修订,以期指导对结直肠癌肝转移患者进行全面评估,个性化地制定治疗目标,开展相应的综合治疗,达到预防结直肠癌肝转移的发生、提高肝转移灶手术切除率和改善5年生存率的目的。本次修订后的2020版《指南》包括结直肠癌肝转移的诊断和随访、预防、MDT 作用、手术治疗和局部毁损治疗、可达到“无疾病证据”状态结直肠癌肝转移的新辅助和辅助治疗、无法达到“无疾病证据”状态结直肠癌肝转移的综合治疗等六部分,汇集总结国内外该领域的先进经验和最新成果,内容详尽,可操作性强。

相关资料下载:
[AttachmentFileName(sort=1, fileName=中国结直肠癌肝转移诊断和综合治疗指南(V2020).pdf)] GetToolGuiderByIdResponse(projectId=1, id=58d1e1c002066373, title=中国结直肠癌肝转移诊断和综合治疗指南(V2020), enTitle=, guiderFrom=中华胃肠外科杂志, authorId=0, author=, summary=2020版《指南》包括结直肠癌肝转移的诊断和随访、预防、MDT 作用、手术治疗和局部毁损治疗、可达到“无疾病证据”状态结直肠癌肝转移的新辅助和辅助治疗、无法达到“无疾病证据”状态结直肠癌肝转移的综合治, cover=, journalId=0, articlesId=null, associationId=0, associationName=, associationIntro=, copyright=0, guiderPublishedTime=Sat Mar 06 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<p><span style="color: #231f20;">肝脏是结直肠癌血行转移最主要的靶器官,</span><span style="color: #231f20;">结直肠癌肝转移是结直肠癌治疗的重点和难点之一。为了</span><span style="color: #231f20;">提高我国结直肠癌肝转移的诊断和综合治疗水平,自</span><span style="color: #231f20;">2008</span><span style="color: #231f20;">年</span><span style="color: #231f20;">开始编写《中国结直肠癌肝转移诊断和综合治疗指南》并后</span><span style="color: #231f20;">续进行了多次修订,以期指导对结直肠癌肝转移患者进行</span><span style="color: #231f20;">全面评估,个性化地制定治疗目标,开展相应的综合治疗,</span><span style="color: #231f20;">达到预防结直肠癌肝转移的发生、提高肝转移灶手术切除</span><span style="color: #231f20;">率和改善</span><span style="color: #231f20;">5</span><span style="color: #231f20;">年生存率的目的。本次修订后的</span><span style="color: #231f20;">2020</span><span style="color: #231f20;">版《指南》</span><span style="color: #231f20;">包括结直肠癌肝转移的诊断和随访、预防、</span><span style="color: #231f20;">MDT </span><span style="color: #231f20;">作用、手术</span><span style="color: #231f20;">治疗和局部毁损治疗、可达到&ldquo;无疾病证据&rdquo;状态结直肠癌</span><span style="color: #231f20;">肝转移的新辅助和辅助治疗、无法达到&ldquo;无疾病证据&rdquo;状态</span><span style="color: #231f20;">结直肠癌肝转移的综合治疗等六部分,汇集总结国内外该</span><span style="color: #231f20;">领域的先进经验和最新成果,内容详尽,可操作性强。</span></p>, tagList=[TagDto(tagId=2142, tagName=结直肠癌肝转移), TagDto(tagId=9119, tagName=结直肠肿瘤)], categoryList=[CategoryDto(categoryId=76, categoryName=胃肠外科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=91, categoryName=肝胆胰外科, tenant=100), CategoryDto(categoryId=20620, categoryName=肿瘤医学网, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=0, guiderKeyword=, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=, guiderLanguage=0, guiderRegion=3, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=10918, appHits=372, showAppHits=0, pcHits=763, showPcHits=10546, likes=1, shares=44, comments=11, approvalStatus=1, publishedTime=Sat Mar 06 20:49:57 CST 2021, publishedTimeString=2021-03-06, pcVisible=1, appVisible=1, editorId=5434489, editor=宁咸襄, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=3, createdBy=null, createdName=宁咸襄, createdTime=Sat Mar 06 20:49:52 CST 2021, updatedBy=5434489, updatedName=宁咸襄, updatedTime=Sat Jan 06 19:31:38 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=中国结直肠癌肝转移诊断和综合治疗指南(V2020).pdf)])
中国结直肠癌肝转移诊断和综合治疗指南(V2020).pdf
下载请点击:
评论区 (9)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1205792, encodeId=e5a81205e925b, content=学习了,谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6b905522600, createdName=ms6980619036574494, createdTime=Fri Mar 25 09:33:00 CST 2022, time=2022-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1061871, encodeId=ce8d10618e188, content=非常有用<a href='/topic/show?id=aa0582e6946' target=_blank style='color:#2F92EE;'>#肿瘤#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82769, encryptionId=aa0582e6946, topicName=肿瘤)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=12d75586812, createdName=ms8000001549818402, createdTime=Tue Oct 19 16:19:36 CST 2021, time=2021-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1012464, encodeId=3bb510124647b, content=好资源,谢谢!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJ1CXL3QKAG2ibC1mTEnpicKoFOLVPgO2ibqP9uLltgEw1M9kC1Siay0UH7zbYb8tEfVvDdlAu0nejLzw/132, createdBy=94bf109446, createdName=wquick, createdTime=Sun Aug 29 06:38:06 CST 2021, time=2021-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1002996, encodeId=30f7100299625, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=caf05557730, createdName=ms3000000586608590, createdTime=Tue Jul 27 14:04:29 CST 2021, time=2021-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1001436, encodeId=bf80100143673, content=学习一下, beContent=null, objectType=guider, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210518/fa104ed2b90f4506a46ec6296a636759/4f32978c738249c8b427991e3551f790.jpg, createdBy=d1425503466, createdName=不会弯的小直君, createdTime=Wed Jul 21 17:52:00 CST 2021, time=2021-07-21, status=1, ipAttribution=)]
    2022-03-25 ms6980619036574494

    学习了,谢谢分享

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1205792, encodeId=e5a81205e925b, content=学习了,谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6b905522600, createdName=ms6980619036574494, createdTime=Fri Mar 25 09:33:00 CST 2022, time=2022-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1061871, encodeId=ce8d10618e188, content=非常有用<a href='/topic/show?id=aa0582e6946' target=_blank style='color:#2F92EE;'>#肿瘤#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82769, encryptionId=aa0582e6946, topicName=肿瘤)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=12d75586812, createdName=ms8000001549818402, createdTime=Tue Oct 19 16:19:36 CST 2021, time=2021-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1012464, encodeId=3bb510124647b, content=好资源,谢谢!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJ1CXL3QKAG2ibC1mTEnpicKoFOLVPgO2ibqP9uLltgEw1M9kC1Siay0UH7zbYb8tEfVvDdlAu0nejLzw/132, createdBy=94bf109446, createdName=wquick, createdTime=Sun Aug 29 06:38:06 CST 2021, time=2021-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1002996, encodeId=30f7100299625, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=caf05557730, createdName=ms3000000586608590, createdTime=Tue Jul 27 14:04:29 CST 2021, time=2021-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1001436, encodeId=bf80100143673, content=学习一下, beContent=null, objectType=guider, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210518/fa104ed2b90f4506a46ec6296a636759/4f32978c738249c8b427991e3551f790.jpg, createdBy=d1425503466, createdName=不会弯的小直君, createdTime=Wed Jul 21 17:52:00 CST 2021, time=2021-07-21, status=1, ipAttribution=)]
    2021-10-19 ms8000001549818402

    非常有用#肿瘤#

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1205792, encodeId=e5a81205e925b, content=学习了,谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6b905522600, createdName=ms6980619036574494, createdTime=Fri Mar 25 09:33:00 CST 2022, time=2022-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1061871, encodeId=ce8d10618e188, content=非常有用<a href='/topic/show?id=aa0582e6946' target=_blank style='color:#2F92EE;'>#肿瘤#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82769, encryptionId=aa0582e6946, topicName=肿瘤)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=12d75586812, createdName=ms8000001549818402, createdTime=Tue Oct 19 16:19:36 CST 2021, time=2021-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1012464, encodeId=3bb510124647b, content=好资源,谢谢!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJ1CXL3QKAG2ibC1mTEnpicKoFOLVPgO2ibqP9uLltgEw1M9kC1Siay0UH7zbYb8tEfVvDdlAu0nejLzw/132, createdBy=94bf109446, createdName=wquick, createdTime=Sun Aug 29 06:38:06 CST 2021, time=2021-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1002996, encodeId=30f7100299625, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=caf05557730, createdName=ms3000000586608590, createdTime=Tue Jul 27 14:04:29 CST 2021, time=2021-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1001436, encodeId=bf80100143673, content=学习一下, beContent=null, objectType=guider, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210518/fa104ed2b90f4506a46ec6296a636759/4f32978c738249c8b427991e3551f790.jpg, createdBy=d1425503466, createdName=不会弯的小直君, createdTime=Wed Jul 21 17:52:00 CST 2021, time=2021-07-21, status=1, ipAttribution=)]
    2021-08-29 wquick

    好资源,谢谢!

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1205792, encodeId=e5a81205e925b, content=学习了,谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6b905522600, createdName=ms6980619036574494, createdTime=Fri Mar 25 09:33:00 CST 2022, time=2022-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1061871, encodeId=ce8d10618e188, content=非常有用<a href='/topic/show?id=aa0582e6946' target=_blank style='color:#2F92EE;'>#肿瘤#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82769, encryptionId=aa0582e6946, topicName=肿瘤)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=12d75586812, createdName=ms8000001549818402, createdTime=Tue Oct 19 16:19:36 CST 2021, time=2021-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1012464, encodeId=3bb510124647b, content=好资源,谢谢!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJ1CXL3QKAG2ibC1mTEnpicKoFOLVPgO2ibqP9uLltgEw1M9kC1Siay0UH7zbYb8tEfVvDdlAu0nejLzw/132, createdBy=94bf109446, createdName=wquick, createdTime=Sun Aug 29 06:38:06 CST 2021, time=2021-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1002996, encodeId=30f7100299625, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=caf05557730, createdName=ms3000000586608590, createdTime=Tue Jul 27 14:04:29 CST 2021, time=2021-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1001436, encodeId=bf80100143673, content=学习一下, beContent=null, objectType=guider, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210518/fa104ed2b90f4506a46ec6296a636759/4f32978c738249c8b427991e3551f790.jpg, createdBy=d1425503466, createdName=不会弯的小直君, createdTime=Wed Jul 21 17:52:00 CST 2021, time=2021-07-21, status=1, ipAttribution=)]
    2021-07-27 ms3000000586608590

    学习

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1205792, encodeId=e5a81205e925b, content=学习了,谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6b905522600, createdName=ms6980619036574494, createdTime=Fri Mar 25 09:33:00 CST 2022, time=2022-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1061871, encodeId=ce8d10618e188, content=非常有用<a href='/topic/show?id=aa0582e6946' target=_blank style='color:#2F92EE;'>#肿瘤#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82769, encryptionId=aa0582e6946, topicName=肿瘤)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=12d75586812, createdName=ms8000001549818402, createdTime=Tue Oct 19 16:19:36 CST 2021, time=2021-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1012464, encodeId=3bb510124647b, content=好资源,谢谢!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJ1CXL3QKAG2ibC1mTEnpicKoFOLVPgO2ibqP9uLltgEw1M9kC1Siay0UH7zbYb8tEfVvDdlAu0nejLzw/132, createdBy=94bf109446, createdName=wquick, createdTime=Sun Aug 29 06:38:06 CST 2021, time=2021-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1002996, encodeId=30f7100299625, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=caf05557730, createdName=ms3000000586608590, createdTime=Tue Jul 27 14:04:29 CST 2021, time=2021-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1001436, encodeId=bf80100143673, content=学习一下, beContent=null, objectType=guider, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210518/fa104ed2b90f4506a46ec6296a636759/4f32978c738249c8b427991e3551f790.jpg, createdBy=d1425503466, createdName=不会弯的小直君, createdTime=Wed Jul 21 17:52:00 CST 2021, time=2021-07-21, status=1, ipAttribution=)]
    2021-07-21 不会弯的小直君

    学习一下

    0